| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The management board of Evotec SE (Frankfurt Stock Exchange, TRQX:EVTd, ISIN: US30050E1055) resolved on 6 November 2025 to implement a share repurchase program.
During the period from 7 November 2025 until 17 December 2025, it is intended to acquire up to 290,000 Evotec shares at a total purchase price of up to EUR 3,000,000 excluding incidental acquisition costs. The acquisition will be effected exclusively via electronic trading on the Frankfurt Stock Exchange (Xetra).
The management board makes use of the authorization to acquire treasury shares as provided for in Section 71(1) No. 2 German Stock Corporation Act (AktG). The shares repurchased under the program shall, after their acquisition by the company, be converted into American Depositary Shares (ADS). These ADS shall be used exclusively to fulfil corresponding obligations under an employee share programme and shall be issued only to individuals who are or were employed by the company or an affiliated company.
The repurchase will be carried out in accordance with the safe harbour provisions of Article 5 of Regulation (EU) No. 596/2014 in conjunction with the provisions of Delegated Regulation (EU) No. 2016/1052 and in compliance with the requirements of Rule 10b5-1(c)(1)(i) paragraphs (A) and (B) under the U.S. Securities Exchange Act of 1934.
The repurchase will be carried out on behalf of Evotec SE by an independent credit institution. The credit institution makes its decisions on the timing of the acquisition of Evotec SE shares independently and uninfluenced by Evotec SE in accordance with Article 4(2)(b) of Delegated Regulation (EU) No. 2016/1052.
Posted In: EVO
